Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Gemmel, C
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. [electronic resource] - Annals of hematology Feb 2002 - 119-23 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0939-5555
10.1007/s00277-001-0397-4 doi
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Combined Modality Therapy
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Plasma Cell--therapy
Male
Middle Aged
Remission Induction
Rituximab
Transplantation, Autologous
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. [electronic resource] - Annals of hematology Feb 2002 - 119-23 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0939-5555
10.1007/s00277-001-0397-4 doi
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Combined Modality Therapy
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Plasma Cell--therapy
Male
Middle Aged
Remission Induction
Rituximab
Transplantation, Autologous